packageInfigratinib

infigratinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Infigratinib is a protein kinase inhibitor that was developed to treat cholangiocarcinoma (bile duct cancer). It is no longer in use: its marketing application in the European Union was withdrawn, and it is listed as withdrawn elsewhere.

Summary written by glm-5.3-flash from Wikidata Q27075200 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:infigratinib
ATC codes:L01EN03
DrugBank:DB11886
PubChem CID:53235510
ChEBI:63451
Wikidata:Q27075200
formula:C26H31Cl2N7O3
molar mass:560.48 g/mol (PubChem CID 53235510)
logP:4.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown